News

Core Happenings

April 2018: Mini symposium on single cell sequencing and NexTSeq system

The GATC organized its first Genomic Technology Mini Symposium on April 9 in Pinn Hall.  Click here to see the April 9 event agenda.

The event also marked the launch of a mini grant program to facilitate access to  genomics NGS resources for the generation of preliminary data for grant applications.  The announcement for this mini grant program can be found here.

The winner of this years’ mini grant program is Dr. Weibin Shi Professor of Radiology & Medical Imaging for his proposal titled: “Rcn2 and Early-Onset Dystonia”

Congratulations Dr. Shi!

Click the links to see a description of the 10X Genomics Chromium single cell system Gene Expression System and the technical presentation from Illumina.

January 2018: A New Year, a New Name!

The DNA Sciences Core has been recently restructured and renamed the Genome Analysis and Technology Core (GATC), to reflect its full genomics core capabilities.

Happy New Year and Best Wishes from the GATC Team (Alyson, Yongde and Katia)

November 2017: New Single Cell Analysis Services!

We are pleased to announce the acquisition, thanks to generous support from the School of Medicine ORCA, of a 10X Genomics Chromium Single Cell Controller and the establishment of new core services in single cell RNA Seq. The instrument is dedicated to single cell applications compatible with the Illumina NGS platforms. The 10X performs high-resolution transcriptome profiling of a single cell, and analysis of heterogeneous gene expression patterns within cell cultures, tissues, and organs.

Stay tuned: Future single cell services will include full-length sequencing of paired expressed V(D)J segments from single B or T cells as well as single cell genomics.  Please contact the core Director Katia Sol-Church (ks5uq@virginia.edu) for detail on sample submission.

July 27, 2017:  We have a new core Director!

Dr. Katia Sol-Church (ks5uq@virginia.edu, ph. 434.924.9953) Research Professor in the Department of Pathology, School of Medicine is the new Director of the core.

Katia comes to us with 16 years of experience in core operations as Director of the Biomolecular Core Laboratory at the Alfred I. duPont Hospital for Children in Wilmington DE, where she also established a successful collaborative clinical research program focused on rare genetic skeletal dysplasia and dysmorphology syndromes.

As the new lead, Katia will develop the DNA Sciences Core  facility into a comprehensive Genomic Analysis and Technology Core with continuing mission to provide sustainable and cost effective core services in support of Basic and Biomedical research.